A Study to Evaluate the Efficacy of Eicosapentanoic Acid on Patients with Major Depression
Alaa Hassan El-Sayed El-Baz;
Abstract
ajor depressive disorder is a medical disease that affects how you feel, think and perform caus¬ing persistent feelings of unhappiness and loss of interest in previously enjoyed activities.
It is a severe, recurrent disorder linked to reduced role functioning and quality of life, medical morbidity, and mortality. The World Health Organization positions depression as the fourth leading cause of disability worldwide, and projects that by 2020, it will be the second leading cause of death.
The etiology of MDD remains poorly understood. But the theories state that there is deficits of neurotransmitters (e.g., serotonin, noradrenaline and dopamine) or dysfunctional hypothalamic–pituitary adrenal (HPA) axis which may contribute to the illness.
It is a severe, recurrent disorder linked to reduced role functioning and quality of life, medical morbidity, and mortality. The World Health Organization positions depression as the fourth leading cause of disability worldwide, and projects that by 2020, it will be the second leading cause of death.
The etiology of MDD remains poorly understood. But the theories state that there is deficits of neurotransmitters (e.g., serotonin, noradrenaline and dopamine) or dysfunctional hypothalamic–pituitary adrenal (HPA) axis which may contribute to the illness.
Other data
| Title | A Study to Evaluate the Efficacy of Eicosapentanoic Acid on Patients with Major Depression | Other Titles | دراسة لتقييم مدى فاعلية حمض الإيكوزابنتانويك فى مرضى الاكتئاب الشديد | Authors | Alaa Hassan El-Sayed El-Baz | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.